This may be because normal cell lines show no c-jun activity, while IL-13Rα2-negative pancreatic cancer cell lines show a 2-6 fold increase in c-jun activity indicating that TSA induction of high levels of IL-13Rα2 is dependent on the AP-1/c-jun pathway. This evidence concerns the gene IL13RA2 and familial pancreatic carcinoma.